Cost of migration: Invasion of malignant gliomas and implications for treatment

Journal of Clinical Oncology

Volumn 21, Issue 8, 2003, Pages 1624-1636

  Giese, Alf ^a   Bjerkvig, R ^a   Berens, M E ^a   Westphal, M ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL ACTIVATION; CELL COUNT; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CORRELATION ANALYSIS; EVIDENCE BASED PRACTICE; GENE CONTROL; GENE EXPRESSION; GLIA CELL; GLIOBLASTOMA; GLIOMA CELL; HEMISPHERECTOMY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; UPREGULATION; BRAIN TUMOR; CELL MOTION; GENETICS; GLIOMA; PATHOLOGY;

BRAIN NEOPLASMS; CELL MOVEMENT; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; PHENOTYPE;

EID: 0038179723     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.05.063     Document Type: Review

References (161)

1. Lacroix M, Abi-Said D, Fourney DR, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001
2. Guthrie BL, Laws ER Jr: Supratentorial low-grade gliomas. Neurosurg Clin N Am 1:37-48, 1990
3. Burger PC, Dubois PJ, Schold SC, et al: Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58:159-169, 1983
4. Gaspar LE, Fisher BJ, MacDonald DR, et al: Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol 24:55-57, 1992
5. Giese A, Westphal M: Treatment of malignant glioma: A problem beyond the margins of resection. J Cancer Res Clin Oncol 127:217-225, 2001
6. Barnard RO, Geddes JF: The incidence of multifocal cerebral gliomas. Cancer 60:1519-1531, 1987
7. Batzdorf U, Malamud N: The problem of multicentric gliomas. Neurosurgery 20:122-136, 1970
8. Budka H, Prodeka I, Reisner T, et al: Diagnostic and pathomorphological aspects of glioma multiplicity. Neurosurg Rev 3:233-241, 1980
9. Scherer HJ: The forms of growth in gliomas and their practical significance. Brain 63:1-35, 1940
10. Silbergeld DL, Rostomily RC, Alvord EC Jr: The cause of death in patients with glioblastoma is multifactorial: Clinical factors and autopsy findings in 117 cases of supratentorial glioblastomas in adults. J Neurooncol 10:179-185, 1991
11. Scherer HJ: Structural development in gliomas. Am J Cancer 34:333-351, 1938
12. Dandy WE: Removal of the right hemisphere for certain tumors with hemiplegia: Preliminary report. J Am Med Assoc 90:823-825, 1928
13. Dandy WE: Physiological studies following extirpation of the right cerebral hemisphere in man. Johns Hopkins Hosp Bull 53:31-51, 1933
14. Bell E, Karnosh LJ: Cerebral hemispherectomy: Report of a case ten years after operation. J Neurosurg 6:285-293, 1949
15. Gardner WJ: Removal of the right hemisphere for infiltrating glioma. Arch Neurol Psychiat Chicago 28:470, 1932
16. Gardner WJ: Removal of the right hemisphere for infiltrating glioma: A report of a case. J Am Med Assoc 101:823-825, 1933
17. MacCarty CS: Surgical treatment of gliomas of the brain. J Int Coll Surg 23:290-297, 1955
18. Matsukado Y, MacCarty CS, Kernohan JW: The growth of glioblastoma multiforme in neurosurgical practice. J Neurosurg 18:636-644, 1961
19. White RJ, MacMarty CS: Cranial nerve function following total cerebral hemispherectomy in the monkey. Proc Mayo Clin 34:22-29, 1959
20. White RJ, MacMarty CS, Grindlay JH, et al: Operative techniques and principles utilized in total hemispherectomy in the monkey and the dog. Proc Mayo Clin 34:13-22, 1959
21. Bailey P, Chushing H: Classification of the tumors of the glioma group on a histogenic basis with a correlated study of prognosis. Philadelphia, PA, Lippincott, 1926, pp 113-118
22. Cobb CA, Youmans JR: Glial and neuronal tumors of the brain in adults, in Youmans JR (ed): Neurological Surgery, Volume 5 (ed 2). Philadelphia, PA, WB Saunders Co, 1982. pp 2812-2813
23. Walter MD, Alexander E, Hunt WE: Evaluation of BCNU and/or radiation therapy in the treatment of anaplastic gliomas. J Neurosurg 49:333-343, 1978
24. Walter MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725-1731, 1979
25. Leibel SA, Sheline GE: Radiation therapy for neoplasms of the brain. J Neurosurg 66:1-22, 1987
26. Green SB, Byar DB, Strike TA, et al: Randomized comparisons of single or multiple drug chemotherapy combined with either whole brain or whole brain plus coned-down boost radiotherapy for the post-operative treatment of malignant gliomas (Study 8001). Proc Am Soc Clin Oncol 5:135, 1986 (abstr)
27. Blacklock JB, Wright DC, Dedrick RL: Drug streaming during intraarterial chemotherapy. J Neurosurg 64:284-291, 1986
28. Cristante L, Siepmann G, Westphal M, et al: Superselective application of cisplatinum in recurrent human glioblastoma. Reg Cancer Treat 4:188-194, 1992
29. Shapiro WR, Green S: Reevaluating the efficacy of intraarterial BCNU. J Neurosurg 66:313-315, 1987
30. Elliott PJ, Hayward NJ, Huff MR, et al: Unlocking the blood-brain-barrier: A role for RMP-7 in brain tumor therapy. Exp Neurol 141:214-224, 1996
31. Gregor A, Lind M, Newman H, et al: Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma: RMP-7 European Study Group. J Neurooncol 2:137-145, 1999
32. Shapiro WR, Green SB, Burger PC, et al: A randomised comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76:772-781, 1992
33. McComb RD, Moul JM, Bigner DD: Distribution of type VI collagen in human gliomas: Comparison with fibronectin and glioma-mesenchymal matrix glycoprotein. J Neuropathol Exp Neurol 46:623-633, 1987
34. Paulus W, Roggendorf W, Schuppan D: Immunohistochemical investigation of collagen subtypes in human glioblastomas. Virchows A Pathol Anat Histopathol 413:325-332, 1988
35. Rutka JT, Myatt CA, Giblin JR, et al: Distribution of extracellular matrix proteins in primary human brain tumors: An immunohistochemical analysis. Can J Neurol Sci 14:25-30, 1987
36. Rutka JT, Apodaca G, Stern R, et al: The extracellular matrix of the central and peripheral nervous systems: Structure and function. J Neurosurg 69:155-170, 1988
37. Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery 39:235-252, 1996
38. Burger PC, Kleihues P: Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsy. Cancer 63:2014-2023, 1989
39. Kleihues P, Ohgaki H: Primary and secondary glioblastoma: From concept to clinical diagnosis. Neuro-oncol 1:44-51, 1999
40. Burger PC, Heinz ER, Shibata T, et al: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698-704, 1988
41. Giangaspero F, Burger PC: Correlation between cytologic composition and biologic behavior in the glioblastoma multiforme: A post mortem study of 50 cases. Cancer 52:2320-2333, 1983
42. Johnson HA, Haymaker WE, Rubin JR: A radiographic study of a human brain and glioblastoma multiforme after the in vivo uptake of tritiated thymidine. Cancer 13:636-642, 1960
43. Hoshino T, Wilson CB, Ellis WG: Gemistocytic astrocytes in gliomas: An autoradiographic study. J Neuropath Exp Neurol 34:263-281, 1975
44. Manuelidis EE: The fate of serial heterologously transplanted glioblastoma multiforme in the eye of the guinea pig. Am J Pathol 48:65-89, 1966
45. Jones TG, Bigner SH, Schold SC, et al: Anaplastic human glioma grown in athymic mice: Morphology and glial fibrillary acid protein expression. Am J Pathol 105:316-327, 1981
46. Sallinen SL, Sallinen PK, Haapasalo HK, et al: Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 60:6617-6622, 2000
47. Huang H, Colella S, Kurrer M, et al: Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res 60:6868-6874, 2000
48. Ljubimova JY, Lakhter AJ, Loksh A, et al: Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res 61:5601-5610, 2001
49. Xu X, Joh HD, Pin S, et al: Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype. Cancer Lett 171:67-77, 2001
50. Kraus JA, Wenghoefer M, Glesmann N, et al: TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme. J Neurooncol 52:263-272, 2001
51. Fuller GN, Hess KR, Rhee CH, et al: Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets Brain Pathol 12:108-116, 2002
52. Liotta LA: Tumor invasion and metastases: Role of the extracellular matrix-Rhoads Memorial Award lecture. Cancer Res 46:1-7, 1986
53. Binder DK, Berger MS: Proteases and the biology of glioma invasion. J Neurooncol 56:149-158, 2002
54. Uhm JH, Dooley NP, Villemure J-G, et al: Mechanisms of glioma invasion: Role of matrix-metalloproteinases. Can J Neurol Sci 24:3-15, 1997
55. Pedersen PH, Marienhagen K, Mork S, et al: Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. Cancer Res 53:5158-5165, 1993
56. Giese A, Loo MA, Rief MD, et al: Substrates for astrocytoma invasion. Neurosurgery 37:294-302, 1995
57. Giese A, Kluwe L, Laube B, et al: Migration of human glioma cells on myelin. Neurosurgery 38:755-764, 1996
58. Giese A, Loo MA, Norman SA, et al: Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. J Cell Sci 109:2161-2168, 1996
59. Giese A, Rief MD, Loo MA, et al: Determinants of human astrocytoma migration. Cancer Res 54:3897-3904, 1994
60. Palacek SP, Loftus JC, Ginsberg MH, et al: Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 385:537-540, 1997
61. Kaczmarek E, Zapf S, Bouterfa H, et al: Dissecting glioma invasion: Interrelation of adhesion, migration and intercellular contacts determine the invasive phenotype. Int J Dev Neurosci 17:625-641, 1999
62. Woodward DE, Cook J, Tracqui P, et al: A mathematical model of glioma growth: The effect of extent of surgical resection. Cell Prolif 29:269-288, 1996
63. Silbergeld DL, Chicoine MR: Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 86:525-531, 1997
64. Mariani L, McDonough WS, Hoelzinger DB, et al: Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. Cancer Res 61:4190-4196, 2001
65. Huettenlocher A, Sandborg RR, Horwitz AF: Adhesion in cell migration. Curr Opin Cell Biol 7:679-706, 1995
66. Giese A, Laube B, Zapf S, et al: Differential glioma cell adhesion and migration on human brain sections. Anticancer Res 18:2435-2448, 1998
67. Giese A, Loo MA, Tran N, et al: Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67:275-282, 1996
68. Giese A, Schröder F, Steiner A, et al: Migration of human glioma cells in response to tumor cyst fluids. Acta Neurochir (Wien) 138:1331-1340, 1996
69. Merzak A, McCrea S, Koocheckpour S, et al: Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br J Cancer 70:199-203, 1994
70. McDonough W, Tran N, Giese A, et al: Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol 55:449-455, 1998
71. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992
72. Kornberg L, Earp HS, Parsons JT, et al: Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion associated tyrosine kinase. J Biol Chem 267:23439-23442, 1992
73. Luna EJ, Hitt AL: Cytoskeleton-plasma membrane interactions. Science 258:955-964, 1992
74. van der Flier A, Sonnenberg A: Function and interactions of integrins. Cell Tissue Res 305:285-298, 2001
75. Schwarz MA: Integrin signaling revisited. Trends Cell Biol 11:466-470, 2001
76. Martin KH, Slack JK, Boerner SA, et al: Integrin connections map: To infinity and beyond. Science 296:1652-1653, 2002
77. Darlymple JS, Parisi JE, Roche PC, et al: Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajectory. Neurosurgery 35:1036-1045, 1994
78. Schiffer D, Cavalla P, Dutto A, et al: Cell proliferation and invasion in malignant gliomas. Anticancer Res 17:61-70, 1997
79. Evan G, Littlewood T: A matter of life and cell death. Science 281:1317-1322, 1998
80. Cho SY, Klemke RL: Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix. J Cell Biol 149:223-236, 2000
81. Mariani L, Beaudry C, McDonough WS, et al: Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: A cDNA microarray analysis. J Neurooncol 53:161-176, 2001
82. Mariani L, Beaudry C, McDonough WS, et al: Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Clin Cancer Res 7:2480-2489, 2001
83. Giese A, Hagel C, Kim EL, et al: Thromboxane synthase regulates the migratory phenotype of human glioma cells. Neuro-oncol 1:3-13, 1999
84. Blackman SC, Dawson G, Antonakis K, et al: The identification and characterization of oligodendrocyte thromboxane A2 receptors. J Biol Chem 273:475-483, 1998
85. Inagaki N, Wada H: Histamine and prostanoid receptors on glial cells. Glia 11:102-109, 1994
86. Nakahata N, Miyamoto A, Ohkubo S, et al: Gq/11 communicates with thromboxane A2 receptors in human astrocytoma cells, rabbit astrocytes and human platelets. Res Commun Mol Pathol Pharniacol 87:243-251, 1995
87. Brass LF, Manning DR, Cichowski K, et al: Signaling through G proteins in platelets: To the integrins and beyond. Thromb Haemost 78:581-589, 1997
88. Shattil SJ, Haimovich B, Cunningham M, et al: Tyrosine phosphorylation of pp125 FAK in platelets requires coordinated signaling through integrins and agonist receptors. J Biol Chem 269:14738-14745, 1994
89. Yoshizato K, Zapf S, Westphal M, et al: Thromboxane synthase inhibitors induces apoptosis in migration arrested glioma cells. Neurosurgery 50:343-354, 2002
90. Maher EA, Furnari FB, Bachoo RM, et al: Malignant glioma: Genetics and biology of a grave matter. Genes Dev 15:1311-1333, 2001
91. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186, 1971
92. Plate KH: Mechanisms of angiogenesis in the brain. J Neuropath Exp Neurol 58:313-320, 1999
93. Pepper MS, Montesano R, Mandriota SJ, et al: Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49:138-162, 1996
94. Millauer B, Shawver LK, Plate KH, et al: Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 367:576-579, 1994
95. Cheng SY, Huang HJS, Nagane M, et al: Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 93:8502-8507, 1996
96. Plate KH, Breier G, Weich HA, et al: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-847, 1992
97. Schweiki D, Itin A, Soffer D, et al: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992
98. Plate KH, Breier G, Risau W: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4:207-218, 1994
99. Zagzag D, Hooper A, Friedlander DR, et al: In situ expression of angiopoientins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 159:391-400, 1999
100. Herman IM, D'Amore PA: Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol 101:43-52, 1985
101. Wesseling P, Schlingenmann RO, Rietveld FJR, et al: Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: An immuno-light and immuno-electron microscopic study. J Neuropath Exp Neurol 54:304-310, 1995
102. Lindahl P, Johansson BR, Leveen P, et al: Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242-245, 1997
103. Haddah SF, Moore SA, Schelper RL, et al: Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of lioblastoma multiforme. J Neuropath Exp Neurol 51:488-492, 1992
104. Stratmann A, Risau W, Plate HK: Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153:1459-1466, 1998
105. Zagzag D, Amirnovin R, Greco MA, et al: Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis. Lab Invest 80:837-849, 2000
106. Kunkel P, Ulbricht U, Bohlen P, et al: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 51:6624-6628, 2001
107. Quigley MR, Maroon JC: The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. STeurosurgery 29:385-389, 1991
108. Winger MJ, MacDonald DR, Cairncross JG: Supratentorial anaplasic gliomas in adults. J Neurosurg 71:487-493, 1989
109. Burger PC, Green SB: Patient age, histologic features, and length of iurvival in patients with glioblastoma multiforme. Cancer 59:1617-1625, 1987
110. Coffey JR, Lunsford LD, Taylor FH: Survival after stereotactic iiopsy of malignant gliomas. Neurosurgery 22:465-473, 1988
111. Medical Research Council: Prognostic factors for high grade malignant glioma: Development of a prognostic index. J Neurooncol 9:47-55, 1990
112. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival n malignant glial neoplasms. J Neurosurg 78:767-775, 1993
113. Salcman M, Scholtz H, Kaplan RS, et al: Long-term survival in patients with malignant astrocytoma. Neurosurgery 34:213-220, 1994
114. Sneed PK, Prados MD, McDermott MW, et al: Large effect of age in the survival of patients with glioblastoma treated with radiotherapy and irachytherapy boost. Neurosurgery 36:898-903, 1995
115. Barker FG, Chang SM, Larson DA, et al: Age and radiation response in glioblastoma multiforme. Neurosurgery 49:1288-1297, 2001
116. Albert FK, Forsting M, Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 84:45-61, 1994
117. Andreou J, George AE, Wise A, et al: CT prognostic criteria of urvival after malignant glioma surgery. Am J Neuroradiol 4:488-490, 1983
118. Cairncross JG, Pexman JHW, Rathbone MP, et al: Post-operative contrast enhancement in patients with brain tumor. Ann Neurol 17:570-572, 985
119. Ammirati M, Vick N, Liao Y, et al: Effect of extent of surgical esection on survival and quality of life in patients with supratentorial glioblastoma and anaplastic astrocytomas. Neurosurgery 21:201-206, 1987
120. Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: A computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6:338-343, 1988
121. Wallner KE, Galicich JH, Krol G, et al: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytomas. Int J Radiat Oncol Biol Phys 16:1405-1409, 1989
122. Kiwit JC, Floeth FW, Bock WJ: Survival in malignant glioma: Analysis of prognostic factors with special regard to cytoreductive surgery, Zentralbl Neurochir 57:76-88, 1996
123. Nitta T, Sato K: Prognostic implications of the extent of surgical ssection in patients with intracranial malignant gliomas. Cancer 75:2727-731, 1995
124. Burton EC, Prados MD: Malignant gliomas. Curr Treat Options Oncol 1:459-468, 2000
125. Sawaya R: Extent of resection in malignant gliomas: A critical ummary. J Neurooncol 42:303-305, 1999
126. Sawaya R: Fifty years of neurosurgery argue in favor of glioma section. Clin Neurosurg 48:10-19, 2001
127. Lo SS, Cho KH, Hall WA. et al: Does the extent of surgery have an npact on the survival of patients who receive postoperative radiation ierapy for supratentorial low-grade gliomas? Int J Cancer 96:71-78, 2001
128. Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:227-231, 1999
129. Metcalfe SE, Grant R: Biopsy versus resection for malignant gliomas. Cochrane Database Syst Rev 3:CD002034, 2001
130. Salford LG, Brun A, Nirfalk S: Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 69:506-509, 1988
131. Kreth FW, Warnke PC, Scheremet R, et al: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762-766, 1993
132. Toms SA, Ferson DZ, Sawaya R: Basic surgical techniques in the resection of malignant gliomas. J Neurooncol 42:215-226, 1999
133. Salcman M: Supratentorial gliomas: Clinical features and surgical therapy, in Wilkins RH, Rengachary SS (eds): Neurosurgery. New York, NY, McGraw Hill, 1996
134. Ciric I, Ammirati M, Vick NA, et al: Supratentorial gliomas: Surgical considerations and immediate postoperative results. Neurosurgery 21:21-26, 1987
135. Arita N, Taneda M, Hayakawa T: Leptomeningeal dissemination of malignant gliomas: Incidence, diagnosis and outcome. Acta Neurochir (Wien) 126:84-92, 1994
136. Aswad I, Bay J, Rogers L: Leptomeningeal metastasis from supratentorial malignant gliomas. Neurosurgery 19:247-251, 1986
137. Erlich SS, Davis RL: Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 42:2854-2864, 1978
138. Batzdorf U, Golg V: Dispersion of central nervous system tumors: Correlation between clinical aspects and tissue culture studies. J Neurosurg 41:691-698, 1974
139. Salazar OM, Rubin P: The spread of glioblastoma multiforme as a determining factor in the radiation treatment volume. Int J Radiat Oncol Biol Phys 1:627-637, 1976
140. Wilkins RH, Odom GL: Cytological changes in cerebrospinal fluid associated with resection of intracranial neoplasms. J Neurosurg 25:24-34, 1966
141. Grabb PA, Albright AL, Pang D: Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 30:64-71, 1992
142. Vertosick FT, Selker RG: Brain stem and spinal metastases of supratentorial glioblastoma multiforme: A clinical series. Neurosurgery 27:516-522, 1990
143. Elliott PJ, Keles GE, Waite M, et al: Ventricular entry during resection of malignant gliomas: Effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg 80:834-839, 1994
144. Onda K, Tanaka R, Takahashi H, et al: Cerebral glioblastoma with cerebrospinal fluid dissemination: A clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery 25:533-540, 1994
145. Smith DR, Hardman JM, Earle KM: Metastasizing neuroectodermal tumors of the central nervous system. J Neurosurg 31:50-58, 1969
146. Sadik AR, Port R, Garfinkel B, Bravo J: Extracranial metastasis of cerebral glioblastoma multiforme: Case report. Neurosurgery 15:549-551, 1984
147. Obermann HA, Hewitt WC, Kalivoda AJ: Medulloblastoma with distant metastasis. Am J Clin Pathol 39:148-160, 1963
148. Anzil AP: Glioblastoma multiforme with extracranial metastasis in the absence of previous craniotomy. J Neurosurg 33:88-94, 1970
149. Rubinstein LJ: Development of extracranial metastasis from a malignant astrocytoma in the absence of previous craniotomy: Case report. J Neurosurg 26:542-547, 1967
150. Ostertag B, Buschmann H: Wie weit kann Wehrdienstbeschädigung bei geschwulsten angenommen werden? Med Klin 37:351-353, 1941
151. Ostertag B: Der Contre-Coup am splenium und die frage der posttraumatischen gliomentstehung. Monatsschr Unfallheilk 51:10-19, 1944
152. Scheid P: Über geschwulstbildung nach Schussverletzungen. Frankfurt Z Path 51:446-478, 1938
153. Annegers JF, Laws ER, Kurland LT, et al: Head trauma and subsequent brain tumors. Neurosurgery 4:203-206, 1979
154. Stichel CC, Müller WH: The CNS lesion scar: New vistas on an old regeneration barrier. Cell Tissue Res 294:1-9, 1998
155. Hamel W, Westphal M: Growth factors in gliomas revisited. Acta Neurochir (Wien) 142:113-138, 2000
156. Bernstein JJ, Getz R, Jefferson M, et al: Astrocytes secrete basal lamina after hemisection of rat spinal cord. Brain Res 327:135-141, 1985
157. Jaeger CB, Blight AR: Spinal compression injury in guinea pigs: Structural changes of endothelium and its perivascular cell association after blood-brain barrier breakdown and repair. Exp Neurol 144:381-399, 1997
158. Ridet J-L, Malhotra SK, Privat A, et al: Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 20:570-577, 1997
159. Reulen HJ, Graber S, Huber P: Factors affecting the extension of peritumoral brain edema: A CT study. Acta Neurochir (Wien) 95:19-24, 1988
160. Lieberman DM, Laske DW, Morrison PE, et al: Convection-enhanced distribution of large molecules in grey matter during interstitial drug infusion. J Neurosurg 82:1021-1029, 1995
161. Laske DW, Youle RJ, Oldfield EH: Tumor regression with regional distribution of the targeted toxin TF-CRM 107 in patients with malignant brain tumors. Nature Med 3:1362-1368, 1997